Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: review decision - October 2013 information

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive (PDF 109 KB)

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: review proposal information

TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders

TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders (PDF 102 KB)

TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 467 KB)

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: press release information

Download PDF version

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): Equality impact assessment

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal  information

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal announcement information

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal received

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal received (PDF 84 KB)

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): initial scrutiny

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): initial scrutiny (PDF 69 KB)

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to scrutiny

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to scrutiny (PDF 6.8 KB)

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination information

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination (PDF 211 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 152 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the ACD

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee comments

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Novartis (manufacturer) response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Novartis (manufacturer) response (PDF 36 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Nursing response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Nursing response (PDF 23 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Pathologists response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Pathologists response (PDF 9.1 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to ACD

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to ACD (PDF 55 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to evaluation report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to evaluation report (PDF 31 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): commentator comments

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Department of Health response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Department of Health response (PDF 36 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): NHS Quality Improvement Scotland response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): NHS Quality Improvement Scotland response (PDF 9.4 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Pfizer response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Pfizer response (PDF 52 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Welsh Assembly Government response

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Welsh Assembly Government response (PDF 13 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): responses from the Assessment Group

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation document information

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: evaluation report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: overview

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: overview (PDF 261 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: assessment report (PDF 592 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: erratum to the assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: erratum to the assessment report (PDF 52 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: consultee and commentator comments on the assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Department of Health

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Department of Health (PDF 32 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - NHS Quality Improvement Scotland

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - NHS Quality Improvement Scotland (PDF 24 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Novartis

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Novartis (PDF 99 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Pfizer

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Pfizer (PDF 69 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Nursing

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Nursing (PDF 44 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal college of Physicians

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal college of Physicians (PDF 62 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Pathologists

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Pathologists (PDF 33 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Welsh Assembly Government

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Welsh Assembly Government (PDF 38 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: non-manufacturer submissions

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - GIST Support UK

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - GIST Support UK (PDF 20 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - Royal College of Physicians

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - Royal College of Physicians (PDF 23 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): manufacturer submissions - Novartis (executive summary)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): manufacturer submissions - Novartis (executive summary) (PDF 17 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: expert written personal statements

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Cook

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Cook (PDF 14 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Judson

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Judson (PDF 14 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Reid

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Reid (PDF 52 KB)

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Robinson

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final protocol

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final matrix of consultee and commentators

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Institute's response to consultee and commentator comments on the draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): provisional matrix of consultee and commentators